Stockreport

Prognosis for Treatment of Glioblastoma Multiforme Expected to Impact Market Growth for Drug Makers

CNS Pharmaceuticals, Inc.  (CNSP) 
PDF PALM BEACH, Florida, March 3, 2020 /PRNewswire/ -- The global Glioblastoma multiforme (GBM) drugs market, is projected to reach nearly $1.4 billion by 2025, expanding at [Read more]